emDOCs Podcast – Episode 94: GLP-1 Agonist Complications
EMDocs
FEBRUARY 7, 2024
Anaphylaxis and angioedema have been reported, primarily with exendin-based therapies such as exenatide and lixisenatide. 2009 Jun;160(6):909-17. Hypersensitivity/dermatologic: GLP-1 agonists are synthetic peptides; may lead to antibody formation and allergic reaction/injection site reaction. 2018 Apr 17;319(15):1580-1591.
Let's personalize your content